Noguchi T, Kitawaki J, Tamura T, Kanno H, Kim T, Maeda K, Yamamoto T, Okada H
Department of Obstetrics and Gynecology, Kyoto Prefectural University of Medicine.
Nihon Sanka Fujinka Gakkai Zasshi. 1993 Oct;45(10):1123-8.
Aromatase activity, as well as steroid receptors, has been demonstrated in ovarian tumors. Aromatase activity was detected in 35 tumors (81%), PR in 21 tumors (49%) and ER in 13 tumors (30%) out of 43 ovarian tumors (27 benign, 14 malignant and 2 granulosa cell tumors). Moreover, immunohistochemical study demonstrated aromatase cytochrome P-450 (P-450arom) in the tumor tissues. Aromatase activity was significantly greater in PR-positive tumors than in PR-negative tumors (p < 0.002). There was a positive correlation between aromatase activity and the PR level (rs = 0.490, p < 0.001). Thirteen of 14 (93%) malignant tumors showed negative PR with low aromatase activity. However, the presence of ER was not correlated with aromatase activity or the presence of PR. There was a positive correlation among serum levels of estradiol, estrone, androstenedione and testosterone, whereas the serum steroid levels were not correlated with aromatase activity, the PR or ER of ovarian tumors. These results suggest that aromatase activity is correlated with PR in ovarian tumors of postmenopausal women.
在卵巢肿瘤中已证实存在芳香化酶活性以及类固醇受体。在43例卵巢肿瘤(27例良性、14例恶性和2例颗粒细胞瘤)中,35例肿瘤(81%)检测到芳香化酶活性,21例肿瘤(49%)检测到孕激素受体(PR),13例肿瘤(30%)检测到雌激素受体(ER)。此外,免疫组织化学研究在肿瘤组织中证实了芳香化酶细胞色素P - 450(P - 450arom)。PR阳性肿瘤中的芳香化酶活性显著高于PR阴性肿瘤(p < 0.002)。芳香化酶活性与PR水平呈正相关(rs = 0.490,p < 0.001)。14例恶性肿瘤中有13例(93%)PR呈阴性且芳香化酶活性较低。然而,ER的存在与芳香化酶活性或PR的存在无关。雌二醇、雌酮、雄烯二酮和睾酮的血清水平之间呈正相关,而血清类固醇水平与卵巢肿瘤的芳香化酶活性、PR或ER无关。这些结果表明,绝经后女性卵巢肿瘤中的芳香化酶活性与PR相关。